MyAmyloidosisTeam

What a frustrating position to be in — knowing something is happening in your body but feeling like you're waiting for things to get worse before you can act. That tension between "early treatment matters" and "you don't qualify yet" is real, and you're not alone in feeling confused by it.

Your instinct is medically sound Show Full Answer

What a frustrating position to be in — knowing something is happening in your body but feeling like you're waiting for things to get worse before you can act. That tension between "early treatment matters" and "you don't qualify yet" is real, and you're not alone in feeling confused by it.

Your instinct is medically sound. Current treatments work by either stabilizing the TTR protein so it doesn't misfold, or silencing the gene that produces it in the liver. Neither approach can reverse damage that's already occurred — they can only slow or stop further progression. So the logic of "treat before damage happens" makes complete sense.

The challenge is that FDA approvals for these medications were based on clinical trials involving patients who already had measurable cardiac involvement. This means the approved indications are tied to documented heart damage, which is why your cardiologist is drawing that line. Your concern about other parts of your body is also very valid. Wild-type ATTR doesn't only affect the heart — amyloid deposits can affect:

- Tendons (like the shoulder tissue where yours was found)
- Nerves, causing neuropathy
- The spine, causing spinal stenosis
- The carpal tunnel area

A cardiologist, understandably, focuses on the heart. But an amyloidosis specialist — often found at major academic medical centers like Mayo Clinic, where you've already had lab work done — takes a broader view of the whole body.

It may be worth requesting a referral to an amyloidosis specialist or a multidisciplinary amyloidosis clinic. They may have a different perspective on treatment eligibility and can monitor all potentially affected systems, not just the heart.

Also worth asking your doctor about: whether any clinical trials exist for asymptomatic or pre-cardiac ATTR patients, as this is an evolving area of research.

 AI-generated responses are not a substitute for medical advice. These services are not intended to diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.

What’s the Difference Between hATTR and Wild-Type ATTR?

How ATTR Amyloidosis Is Diagnosed: Key Tests